Physician profile
Mark C Meyer
NPI 1902828288
$14,401.46
in general payments reported to CMS, 2019-2025
46 companies · $3,372 in 2025
The $3,372 reported for 2025 was more than what 87% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,215 · 2020: $1,893 · 2021: $1,384 · 2022: $1,177 · 2023: $2,783 · 2024: $1,577 · 2025: $3,372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,448 · Travel and Lodging: $2,284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,447.85 |
| Travel and Lodging | $2,284.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,121.25 | 2019-2025 | General - Pain Management, Intracept, Wavewriter Alpha Prime 16 |
| Nevro Corp. | $2,843.59 | 2019-2024 | Senza |
| Saluda Medical Americas, INC. | $2,123.68 | 2024-2025 | Evoke |
| Abbvie INC. | $880.30 | 2021-2025 | |
| Tersera Therapeutics LLC | $606.83 | 2019-2025 | Prialt |
| Collegium Pharmaceutical, INC. | $592.00 | 2019-2024 | Xtampza, Belbuca |
| Medtronic, INC. | $436.72 | 2023-2025 | Intellis Adaptivestim, Inceptiv, Ascenda |
| Pfizer INC. | $426.80 | 2019-2025 | |
| Abbott Laboratories | $408.12 | 2019-2025 | Eterna, Proclaim |
| Allergan, INC. | $391.15 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $277.77 | 2019-2025 | Relistor |
| Stimwave Technologies Incorporated | $182.92 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $170.99 | 2021 | |
| Idorsia Pharmaceuticals US INC | $161.30 | 2022-2023 | Quviviq |
| Lundbeck LLC | $145.81 | 2024-2025 | Vyepti |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.